AsiaMedic Limited (SGX:505)
Singapore · Delayed Price · Currency is SGD 0.0180
-0.0010 (-5.26%)
At close: Sep 11, 2026
AsiaMedic Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 34.84 | 35.22 | 28.91 | 23.6 | 18.88 | 18.26 |
Other Revenue | 0.03 | 0.07 | 0.17 | 0.15 | 0.16 | 0.17 |
| 34.87 | 35.29 | 29.09 | 23.75 | 19.04 | 18.42 | |
Revenue Growth | 7.31% | 21.34% | 22.46% | 24.72% | 3.38% | 19.81% |
Cost of Revenue | 25.58 | 25.89 | 23.28 | 18.4 | 14.78 | 14.25 |
Gross Profit | 9.29 | 9.4 | 5.8 | 5.35 | 4.27 | 4.17 |
Selling, General & Admin | 1.5 | 1.48 | 1.02 | 0.11 | 0.14 | 0.14 |
Other Operating Expenses | 3.6 | 3.86 | 1.65 | 2.45 | 2.15 | 1.97 |
Operating Expenses | 8.09 | 8.73 | 5.16 | 4.63 | 3.34 | 3.38 |
Operating Income | 1.19 | 0.67 | 0.65 | 0.72 | 0.92 | 0.79 |
Interest Expense | -0.86 | -0.91 | -0.59 | -0.42 | -0.24 | -0.15 |
Interest & Investment Income | 0.18 | 0.23 | 0.17 | 0.17 | 0.04 | 0.02 |
Earnings From Equity Investments | 0.44 | 0.4 | 0.32 | 0.44 | 0.48 | 0.36 |
Other Non Operating Income (Expenses) | 0.11 | 0.11 | 0.02 | - | - | 0.09 |
EBT Excluding Unusual Items | 1.06 | 0.49 | 0.57 | 0.91 | 1.21 | 1.12 |
Impairment of Goodwill | - | - | -0.05 | - | -0.52 | - |
Gain (Loss) on Sale of Assets | 0.94 | 0.94 | - | - | - | - |
Asset Writedown | - | - | 0.12 | 0.12 | 1.5 | -0.86 |
Other Unusual Items | - | - | - | - | - | 0.45 |
Pretax Income | 2.01 | 1.43 | 0.64 | 1.03 | 2.19 | 0.72 |
Income Tax Expense | - | - | -0 | -0.89 | - | - |
Earnings From Continuing Operations | 2.01 | 1.43 | 0.65 | 1.92 | 2.19 | 0.72 |
Minority Interest in Earnings | -0.01 | 0.59 | 0.36 | - | - | - |
Net Income | 1.99 | 2.02 | 1.01 | 1.92 | 2.19 | 0.72 |
Net Income to Common | 1.99 | 2.02 | 1.01 | 1.92 | 2.19 | 0.72 |
Net Income Growth | 85.14% | 100.45% | -47.44% | -12.13% | 205.72% | - |
Shares Outstanding (Basic) | 1,144 | 1,140 | 1,155 | 1,132 | 1,120 | 1,120 |
Shares Outstanding (Diluted) | 1,159 | 1,155 | 1,155 | 1,132 | 1,120 | 1,120 |
Shares Change | 1.48% | 0.05% | 1.97% | 1.13% | - | 2.36% |
EPS (Basic) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS (Diluted) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS Growth | 82.34% | 101.27% | -48.76% | -13.11% | 225.88% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 3.79 | 1.2 | 0.68 | 0.98 | 0.23 | 3.06 |
Free Cash Flow Per Share | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 |
Gross Margin | 26.63% | 26.63% | 19.95% | 22.52% | 22.40% | 22.65% |
Operating Margin | 3.43% | 1.89% | 2.22% | 3.03% | 4.85% | 4.31% |
Profit Margin | 5.71% | 5.73% | 3.47% | 8.09% | 11.48% | 3.88% |
Free Cash Flow Margin | 10.87% | 3.41% | 2.32% | 4.14% | 1.23% | 16.60% |
EBITDA | 2.05 | 1.56 | 1.34 | 1.6 | 1.19 | 1.17 |
EBITDA Margin | 5.87% | 4.42% | 4.59% | 6.74% | 6.24% | 6.35% |
D&A For EBITDA | 0.85 | 0.89 | 0.69 | 0.88 | 0.27 | 0.38 |
EBIT | 1.19 | 0.67 | 0.65 | 0.72 | 0.92 | 0.79 |
EBIT Margin | 3.43% | 1.89% | 2.22% | 3.03% | 4.85% | 4.31% |